|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 403/14 | (2006.01) |
| C07D 401/14 | (2006.01) | ||
| C07D 417/14 | (2006.01) | ||
| A61K 31/4025 | (2006.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 31/4196 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Patento numeris | 2368890 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11160830.3 |
| Europos patento paraiškos padavimo data | 2010-06-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-09-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-04-17 |
| (46) | Apibrėžties vertimo paskelbimo data | 2013-08-26 |
| (30) | Numeris | Data | Šalis |
| 186291 P | 2009-06-11 | US | |
| 242836 P | 2009-09-16 | US | |
| 243596 P | 2009-09-18 | US |
| (72) |
Randolph, John T., US
Degoey, David A., US
Kati, Warren M., US
Hutchins, Charles W., US
Donner, Pamela L., US
Krueger, Allan C., US
Motter, Christopher E., US
Nelson, Lissa T., US
Patel, Sachin V., US
Matulenko, Mark A., US
Keddy, Ryan G., US
Jinkerson, Tammie K., US
Hutchinson, Douglas K., US
Flentge, Charles A., US
Wagner, Charles A., US
Maring, Clarence J., US
Tufano, Michael D., US
Betebenner, David A., US
Rockway, Todd W., US
Liu, Dachun, US
Pratt, John K., US
Sarris, Kathy, US
Woller, Kevin R., US
Wagaw, Seble H., US
Califano, Jean C., US
Li, Wenke, US
Caspi, Daniel D., US
Bellizzi, Mary E., US
Yl, Gao, US
|
| (73) |
AbbVie Manufacturing Management Unlimited Company ,
70 Sir John Rogerson's Quay, Dublin 2,
IE
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Hepatito C viruso inhibitoriai |
| Hepatitis C virus inhibitors |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-05-09 | 16 | 347.00 EUR |
| 2026-06-10 |